Ghrelin - A hormone with multiple functions;Ghrelin: A többfunkciós hormon

Orvosi Hetilap

Volumn 146, Issue 25, 2005, Pages 1345-1351

  Hubina, Erika ^a   Góth, Miklós ^a   Korbonits, Márta ^a,b  

^a Endokrinológiai Szakprofil ^*  (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Cell proliferation; Energy utilization; Ghrelin; Growth hormone; Growth hormone secretagogue

Indexed keywords

CORTICOTROPIN; GHRELIN; GHRELIN RECEPTOR; GROWTH HORMONE; GROWTH HORMONE SECRETAGOGUE RECEPTOR; HORMONE RECEPTOR; INSULIN; MOTILIN; PROLACTIN; UNCLASSIFIED DRUG; PEPTIDE HORMONE;

ARTICLE; BODY MASS; CARBOHYDRATE METABOLISM; CELL METABOLISM; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CORTICOTROPIN RELEASE; FOOD INTAKE; GENE STRUCTURE; GROWTH HORMONE RELEASE; HEART FUNCTION; HEART MUSCLE; HORMONE ACTION; HORMONE SYNTHESIS; HUMAN; HYPERGLYCEMIA; HYPOPHYSIS; HYPOPHYSIS ADENOMA; HYPOTHALAMUS; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INSULIN BLOOD LEVEL; INTESTINE MOTILITY; KIDNEY; LIPID METABOLISM; LUNG; NEUROENDOCRINE TUMOR; OVARY; PANCREAS; PLACENTA; PROLACTIN RELEASE; PROTEIN LOCALIZATION; SPLEEN; STARVATION; STOMACH; STOMACH ACID SECRETION; TESTIS; THYROID CARCINOMA; THYROID GLAND; UPPER GASTROINTESTINAL TRACT; ANIMAL; METABOLISM; PHYSIOLOGY; REVIEW;

ANIMALS; APPETITE REGULATION; CELL PROLIFERATION; HUMANS; PEPTIDE HORMONES;

EID: 24144453167     PISSN: 00306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Andersson, U., Filipsson, K., Abbott, C. R. és mtsai: AMP-activated protein kinase plays a role in the control of food intake. J. Biol. Chem., 2004, 279, 12005-12008.
2. Andervald, C., Brabant, G., Bernroider, E. és mtsai: Insulin-dependent modulation of plasma ghrelin and leptin concentrations is less pronounced in type 2 diabetic patients. Diabetes, 2003, 52, 1792-1798.
3. Arvat, E., Maccario, M., Di Vito, L. és mtsai: Endocrine activities of ghrelin, a natural GH secretagogue, in humans: comparison and interactions with hexarelin, a non natural peptidyl GHS, and GM-releasing hormone. J. Clin. Endocrinol. Metab., 2001, 86, 1169-1174.
4. Asakawa, A., Inni, A., Kaga, T. és mtsai. Antagonism of ghrelin receptor reduces food intake and body weight gain in mice. Cut, 2003, 52, 947-952.
5. Bennett, P. A., Thomas, G. B., Howard, A. D. és mtsai. Hypothalamic growth hormone secretagogue-receptor (GHS-R) expression is regulated by growth hormone in the rat. Endocrinology, 1997, 138, 4552-4557.
6. Bercu, B. B., Yang, S. W., Masuda, R., Walker, R. F.: Role of selected endogenous peptides in growth hormone-releasing hexapeptide activity: analysis of growth hormone-releasing hormone, thyroid hormone-releasing hormone, and gonadotropin- releasing hormone. Endocrinology, 1992, 130, 2579-2586.
7. Bodart, V., Febbraio, M., Demers, A. és mtsai: CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart. Circ. Res. 2002, 90, 844-849.
8. Bowers, C. Y., Chang, J., Momany, F. A. és mtsa: Effect of the enkephalins and enkephalin analogues on release of pituitary hormones in vitro. Mol. Endocrinol., 1977, kötet (8) 287-292.
9. Cowley, M. A., Pronchuk, N., Fan, W. és mtsai: Integration of NPY, AGRP, and melanocortin signals in the hypothalamic paraventricular nucleus: evidence of a cellular basis for the adipostat. Neuron, 1999, 24, 155-163.
10. Cowley, M. A., Smith, R. G., Diano, S. és mtsai: The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron, 2002, 37, 649-661.
11. Cummings, D. E., Purnell, J. Q., Frayo, R. S. és mtsai: A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes, 2001, 50, 1714-1719.
12. Cummings, D. E., Weigle, D. S., Frayo, R. S. és mtsai: Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N. Eng. J. Med., 2002, 346, 1623-1630.
13. Cunha, S. R., Maya, K. E.: Ghrelin and growth hormone (GH) secretagogues potentiate GH-releasing hormone (GHRH)-induced cyclic adenosine 3′,5′-monophosphate production in cells expressing transfected GHRH and GH secretagogue receptors. Endocrinology, 2002, 143, 4570-4582.
14. Date, Y., Murakami, N., Toshinai, K. és mtsai: The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology, 2002, 123, 1120-1128.
15. Dixit, V. D., Schaffer, E. M., Pyle, R. S. és mtsai: Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J. Clin. Invest., 2004, 114, 57-66.
16. Enomoto, M., Nagaya, N., Uematsu, M. és mtsai: Cardiovascular and hormonal effects of subcutaneous administration of Ghrelin, a novel growth hormone-releasing peptide, in healthy humans. Clin. Sci. (Lond.), 2003, 105, 431-435.
17. Gnanapavan, S., Kola, B., Bustin, S. A. és mtsai: The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J. Clin. Endocrinol. Metab., 2002, 87, 2988-2991.
18. Goldstone, A. P., Thomas, E. L., Brynes, A. E. és mtsai: Elevated fasting plasma ghrelin in Prader-Willi syndrome adults is not solely explained by their reduced visceral adiposity and insulin resistance. J. Clin. Endocrinol. Metab., 2004, 89, 1718-1726.
19. Guan, X. M., Yu, H., Palyha, O. C. és mtsai: Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Mol. Brain Res., 1997, 48, 23-29.
20. Hewson, A. K., Tung, L. Y., Conneli D. W. és mtsai: The rat arcuate nucleus integrates peripheral signals provided by leptin, insulin, and a ghrelin mimetic. Diabetes, 2002, 51, 3412-3419.
21. Howard, A. D., Feighner, S. D., Cully, D. F. és mtsai: A receptor in pituitary and hypothalamus that functions in growth hormone release. Science, 1996, 273, 974-977.
22. Ikezaki, A., Hosoda, H., Ito, K. és mtsai: Fasting plasma ghrelin levels are negatively correlated with insulin resistance and PAI-I, but not with leptin, in obese children and adolescents. Diabetes, 2002, 51, 3408-3411.
23. Katugampola, S. D., Kuc, R. E., Maguire, J. J. és mtsa: G-protein-coupled receptors in human atherosclerosis: comparison of vasoconstrictors (endothelin and thromboxane) with recently de- orphanized (urotensin-II, apelin and ghrelin) receptors. Clin. Sci. (Lond.), 2002, 103 (Suppl. 1.), 171S-175S.
24. Katugampola, S. D., Pallikaros, Z., Davenport, A. P.: [125I-His(9)]-ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue: up-regulation of receptors with athersclerosis. Br. J. Pharmacol., 2001, 134, 143-149.
25. Kojima, M., Hosoda, H., Date, Y. és mtsai: Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature, 1999, 402, 656-660.
26. Kola, B., Hubina, E., Tucci, S. A. és mtsai: Ghrelin and cannabinoid effects on food intake and energy metabolism are via AMPK both in the hypothalamus and in the peripheral tissues. Proc of the 87th Annual Meet of the Endocrine Soc. (2005)
27. Korbonits, M., Bitstin, S. A., Kojima, M. és mtsai: The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors. J. Clin. Endocrinol. Metab., 2001, 86, 881-887.
28. Korbonits, M., Grossman, A. B.: Növekedési hormon-serkento peptidek (GHRP) és analógjaik. Orv. Hetil., 1996, 145, 1-7.
29. Korbonits, M., Jacobs, R. A., Aylwin, S. J. B. és mtsai: Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors. J. Clin. Endocrinol. Metab., 1998, 83, 3624-3630.
30. Korbonits, M., Kallsas, G., Perry, L. A. és mtsai: Hexarelin as a test of pituitary reserve in patients with pituitary disease. Clin. Endocrinol. (Oxf.). 1999, 51, 369-375.
31. Korbonits, M., Trainer, P. J., Besser, G. M.: The effect of an opiate antagonist on the hormonal changes induced by hexarelin. Clin. Endocrinol. (Oxf.), 1995, 43, 365-371.
32. Lall, S., Tung, L. Y. C., Ohlsson, C., Jansson, J. O. és mtsai: Growth hormone (GH)-independent stimulation of adiposity by GH secretagogues. Biochem. Biophys. Res. Commun., 2001, 280, 132-138.
33. Leal-Cerro, A., Pumar, A., Garcia-Garcia, E. és mtsai: Inhibition of growth hormone release after the combined administration of GHRH and GHRP-6 in patients with Cushing's syndrome. Clin. Endocrinol. (Oxf.) 1994, 41, 649-654.
34. Leal-Cerro, A., Torres, E., Soto, A. és mtsai: Ghrelin is no longer able to stimulate growth hormone secretion in patients with Cushing's syndrome but instead induces exaggerated corticotropin and cortisol responses. Neuroendocrinology, 2002, 76, 390-396.
35. Mozid, A. M., Tringali, G., Forsling, M. L. és mtsai: Ghrelin is released from rat hypothalamic explants and stimulates corticotrophin-releasing hormone and arginine-vasopressin. Horm. Metab. Res., 2003, 35, 455-459.
36. Nagaya, N., Kangawa, K.: Ghrelin, a novel growth hormone-releasing peptide, in the treatment of chronic heart failure. Regul. Pept., 2003, 114, 71-77.
37. Nagaya, N., Kojima, M., Uematsu, M. és mtsai: Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Amer. Physiol. Regul. Integr. Comp. Physiol., 2001, 280, R1483-R1487.
38. Popovic, V., Damjanovic, S., Micic, D. és mtsai: Blocked growth hormone-releasing peptide (GHRP-6)-induced growth hormone secretion and absence of the synergic action of GHRP-6 plus growth hormone-releasing hormone in patients with hypothalamopituitary disconnection - evidence that GHRP-6 main action is exerted at the hypothalamic level. J. Clin. Endocrinol. Metab., 1995, 80, 942-947.
39. Popovic, V., Leal-Cerro, A., Micic, D. és mtsai: GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults. Lancet, 2000, 356, 1137-1142.
40. Popovic, V., Miljic, D., Micic, D. és mtsai: Ghrelin main action on the regulation of growth hormone release is exerted at hypothalamic level. J. Clin. Endocrinol. Metab., 2003, 88, 3450-3453.
41. Pöykkö, S. M., Kellokoski, E., Horkko, S. és mtsai: Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes, 2003, 52, 2546-2553.
42. Purnell, J. Q., Weigle, D. S., Breen, P. A. és mtsa: Ghrelin levels correlate with insulin levels, insulin resistance, and high-density lipoprotein cholesterol, but not with gender, menopausal status, or cortisol levels in humans. J. Clin. Endocrinol. Metab., 2003, 88, 5747-5752.
43. Smith, R. G., Van der Ploeg, L. H. T., Howard, A. D. és mtsai: Peptidomimetic regulation of growth hormone secretion. Endocrine Rev., 1997, 18, 621-645.
44. Sun, Y., Ahmed, S., Smith, R. G.: Deletion of ghrelin impairs neither growth nor appetite. Mol. Cell Biol., 2003, 23, 7973-7981.
45. Sun, Y., Wang, P., Zheng, H. és mtsa: Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc. Natl. Acad. Sci. USA., 2004, 101, 4679-4684.
46. Takaya, K., Ariyasu, H., Kanamoto, N. és mtsai: Ghrelin strongly stimulates growth hormone release in humans. J. Clin. Endocrinol. Metab., 2000, 85, 4908-4911.
47. Tannenbaum, G. S., Epelbaum, J., Bowers, C. Y.: Interrelationship between the novel peptide ghrelin and somatostatin/growth hormone-releasing hormone in regulation of pulsatile growth hormone secretion. Endocrinology, 2003, 144, 967-974.
48. Tschöp, M., Smiley, D. L., Heiman, M. L: Ghrelin induces adiposity in rodents. Nature, 2000, 407, 908-913.
49. Tschöp, M., Wawarta, R., Riepl, R. L. és mtsai: Post-prandial decrease of circulating human ghrelin levels. J. Endocrinol. Invest., 2001, 24, RC19-RC21.
50. Wells, T., Houston, P. A.: Skeletal growth acceleration with growth hormone secretagogues in transgenic growth retarded rats: pattern-dependent effects and mechanisms of desensitization. J. Neuroendocrinol., 2001, 13, 496-504.
51. Williams, D. L, Grill, H. J., Cummings, D. E. és mtsa: Vagotomy dissociates short- and long-term controls of circulating ghrelin. Endocrinology, 2003, 144, 5184-5187.
52. Wren, A. M., Small, C. J., Fribbens, C. V. és mtsai: The hypothalamic mechanisms of the hypophysiotropic action of ghrelin. Neuroendocrinology, 2002, 76, 316-324.